X
KEY PRODUCTS
https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/biophore-its-subsidiary-zenara-pharma-receive-first-approval-for-cannabidiol-in-india/100251790
https://health.economictimes.indiatimes.com/news/pharma/akums-enters-into-a-joint-association-with-leiutis-and-biophore-for-introducing-first-of-its-kind-therapeutics/95898429
https://www.outlookindia.com/business/zenara-pharma-launches-generic-of-paxlovid-for-covid-19-in-india-news-222189
https://www.biospectrumindia.com/news/95/20420/biophore-to-manufacture-indigenous-ingredients-of-pfizers-covid-19-drug.html
https://www.thehindubusinessline.com/news/natco-biophore-pharma-get-nod-to-manufacture-market-molnupiravir/article64927523.ece
https://www.expresspharma.in/biophore-applies-for-dcgi-approval-for-emergency-use-of-aviptadil-to-treat-covid-19/
https://www.businessinsider.in/science/health/news/fdc-launches-two-variants-of-covid-19-drug-favipiravir-in-india-at-55-per-tablet/articleshow/77754981.cms
https://www.expresspharma.in/drug-approvals/zenara-pharma-a-biophore-subsidiary-gets-dcgi-nod-for-favipiravir-tablets/
Market Place
Share 
